^
DRUG CLASS:

HER2 inhibitor

Related drugs:
EGFR expression
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
EGFR mutation
NSCLC
TMB-H + HER-2 positive
HER2 Positive Breast Cancer
KIF5B-EGFR fusion
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
EGFR exon 19 deletion + PD-L1 overexpression
LUAD
EGFR D770_N771insSVD
LUAD
EGFR L747P
LUAD
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive + CAV1 overexpression
Gastric Cancer
HER-2 positive
HER2 Positive Breast Cancer
EGFR exon 19 deletion
NSCLC
EGFR L858R
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
EGFR mutation
NSCLC
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
Gastric Cancer
HR positive
HER2 Positive Breast Cancer
HER-2 overexpression
Gastric Cancer
HER-2 positive
HER2 Positive Breast Cancer
HER-2 amplification
Hormone Receptor Positive Breast Cancer
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
HER-2 amplification
HER2 Positive Breast Cancer
HER-2 overexpression
HER2 Positive Breast Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 overexpression
Gastric Cancer
HER-2 amplification
Hormone Receptor Positive Breast Cancer
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
HER-2 amplification
HER2 Positive Breast Cancer
HER-2 overexpression
HER2 Positive Breast Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 overexpression
Gastric Cancer
HER-2 amplification
Hormone Receptor Positive Breast Cancer
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
HER-2 amplification
HER2 Positive Breast Cancer
HER-2 overexpression
HER2 Positive Breast Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 overexpression
Gastric Cancer
HER-2 amplification
Hormone Receptor Positive Breast Cancer
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
HER-2 amplification
HER2 Positive Breast Cancer
HER-2 overexpression
HER2 Positive Breast Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 overexpression
Gastric Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 amplification
Hormone Receptor Positive Breast Cancer
HER-2 amplification
HER2 Positive Breast Cancer
HER-2 overexpression
Gastric Cancer
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
HER-2 overexpression
HER2 Positive Breast Cancer
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
HER-2 overexpression
Hormone Receptor Negative Breast Cancer
HER-2 overexpression
Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
HER-2 overexpression
Breast Cancer
HR positive
HER2 Positive Breast Cancer
No biomarker
NSCLC
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Hormone Receptor Positive Breast Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
HER-2 amplification
Hormone Receptor Positive Breast Cancer
HER-2 overexpression
HER2 Positive Breast Cancer
HER-2 overexpression
Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
HER-2 overexpression
Gastroesophageal Junction Adenocarcinoma
HER-2 amplification
Breast Cancer
HER-2 overexpression
Gastric Cancer
HER-2 positive
Gastric Cancer
No biomarker
Lung Non-Small Cell Squamous Cancer
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Gastroesophageal Junction Adenocarcinoma
HER-2 overexpression
Gastroesophageal Junction Adenocarcinoma
HER-2 overexpression
Gastroesophageal Junction Adenocarcinoma
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 positive
Gastric Cancer
No biomarker
Oral Cancer
No biomarker
Oropharyngeal Cancer
HER-2 amplification
CRC
ER positive
HER2 Positive Breast Cancer
HER-2 expression
Endometrial Adenocarcinoma
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
GastroEsophageal Cancer
HER-2 positive
Esophageal Adenocarcinoma
HER-2 overexpression
Esophageal Adenocarcinoma
HR positive
HER2 Positive Breast Cancer
HER-2 positive
Salivary Gland Cancer
HER-2 positive
Endometrial Cancer
HR positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
EGFR expression
Chordoma
HER-2 mutation
NSCLC
HER-2 mutation
NSCLC
HR positive
HER2 Positive Breast Cancer
HR positive
HER2 Positive Breast Cancer
No biomarker
Male Breast Cancer
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our